Abstract:Reverse micelles are nanoaggregates of surfactants that spontaneously form in a non-aqueous solvent. As a transdermal carrier for delivery of hydrophilic drugs, they can effectively control the release of drugs and improve their bioavailability thus achieving therapeutic levels throughout the body. Here, we prepared insulin-loaded reverse micelles composed of isopropyl myristate (IPM) and lecithin as the solvent and the surfactant, respectively. We tuned the amount of lecithin and volume of insulin leading to significant variations in viscosity. The optimal permeation flux was (6.98 ± 2.85) to (8.95 ± 4.74) μg/cm2/h with a gel viscosity of 1079.56–2956.45 cP. The in vitro insulin permeation through hairless mice skin from reverse micelles gel followed zero-order kinetics (R2 = 0.9234–0.9853) over a period of 24 h with case-II transport mechanism. The in vivo study of optimized reverse micelles gel in alloxan-induced diabetic rabbits demonstrated prolonged hypoglycemic effects of at least 12 h after transdermal administration. The optimal relative bioavailability (RBA) value was 136.74% versus the subcutaneous insulin group. We evaluated coarse grained molecular dynamics simulations (CGMD) to explore the permeation mechanism of reverse micelles to improve transdermal drug delivery and modify the viscosity on insulin release. The results indicated that reverse micelles deform after contacting the stratum corneum and penetrate further through it. There is reduced insulin release with increasing viscosity. The CGMD results confirmed the experimental findings.<ol class="links-for-figure"><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S1773224720311801-fx1_lrg.jpg">Download : Download high-res image (276KB)</a></li><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S1773224720311801-fx1.jpg">Download : Download full-size image</a></li></ol>

Ionic liquid-mediated ethosome for transdermal delivery of insulin

Enhancing the Solubility and Transdermal Delivery of Drugs Using Ionic Liquid‐In‐Oil Microemulsions

Ionic liquids for oral insulin delivery

Enhanced Transdermal Delivery of Insulin by Choline-Based Ionic Liquids

Ethosome as a potential transdermal drug delivery system

Poly(3,4-ethylenedioxythiophene):polystyrene sulfonate (PEDOT:PSS) as an insulin carrier in silk fibroin hydrogels for transdermal delivery via iontophoresis

Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin.

Chitosan/lecithin liposomal nanovesicles as an oral insulin delivery system

Formulation of Self-Nanoemulsifying Drug Delivery Systems for Insulin-Soybean Lecithin Complex

Ethosomes: a potential nanovesicular carrier to enhancing the drug delivery against skin barriers

Skin Permeable Polymer for Noninvasive Transdermal Insulin Delivery

Enhanced oral absorption of insulin: hydrophobic ion pairing and a self-microemulsifying drug delivery system using a D-optimal mixture design

Lecithin/isopropyl myristate reverse micelles as transdermal insulin carriers: Experimental evaluation and molecular dynamics simulation

Design and Evaluation of Hydrophobic Ion Paired Insulin Loaded Self Micro-Emulsifying Drug Delivery System for Oral Delivery

Improving the Hypoglycemic Effect of Insulin Via the Nasal Administration of Deep Eutectic Solvents

Ethosomes as a carrier for transdermal drug delivery system: methodology and recent developments

Self-emulsifying drug delivery systems (SEDDS): In vivo-proof of concept for oral delivery of insulin glargine

The in Vitro and in Vivo Study on Self-Nanoemulsifying Drug Delivery System (SNEDDS) Based on Insulin-Phospholipid Complex.

Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions

Enhanced transdermal insulin delivery by electroporation

PEGylated insulin loaded complexation hydrogels for protected oral delivery